A narrative review of considerations when assessing potential relationships between Guillain-Barré syndrome and vaccines
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
Europe PMC Europe PMC 1 Sign in | Create an account https://orcid.org https://plus.europepmc.org Europe PMC Menu About About Europe PMC Preprints in Europe PMC Governance & funding Mission & roadmap Outreach Tools Tools overview Article status monitor ORCID article claiming Grant finder External links service RSS feeds About SciLite annotations Annotations submission service Developers Developer resources Articles RESTful API Grants RESTful API API case studies SOAP web service Annotations API OAI service Bulk downloads Developers Forum Support User guide Search syntax guide Contact us Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus
Related documents
- Vaccines and the risk of Guillain-Barré syndrome: A French pharmacovigilance analysis#126876
- Guillain–Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance study#676798
- A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)#881226
- Screening of signaling pathways and hub genes in Guillain-Barré syndrome based on bioinformatics and machine learning.#736
- Living With Guillain-Barré Syndrome as Children.#1102803
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive